Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.56 |
| ▸ | FLT1 | P17948 | 1/20 | 0.55 |
| ▸ | FLT4 | P35916 | 1/20 | 0.55 |
| ▸ | KDR | P35968 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10887493 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRCASP1SMN1; SMN2GRIK1 | |
| Hydrochloric Acid SCHEMBL10574721 | 0.98 | ALDH1A1 (0.61) | ALDH1A1TSHRCASP1SMN1; SMN2GRIK1 | |
| SCHEMBL7531772 | 0.86 | GRIK1 (0.52) | ALDH1A1SMN1; SMN2GRIK1FLT1FLT4 | |
| SCHEMBL16319459 | 0.86 | TTR (0.53) | ALDH1A1SMN1; SMN2GRIK1FLT1FLT4 | |
| SCHEMBL1921213 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TSHRCASP1SMN1; SMN2GRIK1 | |
| SCHEMBL11398514 | 0.85 | HTT (0.69) | ALDH1A1TSHRCASP1SMN1; SMN2GRIK1 | |
| SCHEMBL8177210 | 0.85 | FLT1 (0.52) | ALDH1A1TSHRCASP1SMN1; SMN2GRIK1 | |
| SCHEMBL498726 | 0.85 | FLT1 (0.55) | ALDH1A1GRIK1FLT1FLT4KDR | |
| SCHEMBL48961 | 0.85 | MRGPRX4 (0.64) | ALDH1A1TSHRHPGDMAPK1TDP1 | |
| SCHEMBL30100412 | 0.85 | MRGPRX4 (0.64) | ALDH1A1TSHRHPGDMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 498 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3551633-B1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS (DK) | 2021-03-31 | — | — | EP | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-0083978-B1 | POLYMER COMPOSITIONS AND THEIR USE IN OR AS ADHESIVE AND OTHER COMPOSITIONS | ROHM AND HAAS COMPANY (US) | 1986-01-08 | — | — | EP | claimed |
| US-4423182-A | CARBOXYLIC CONTAINING POLYMER WITH METAL SALT OF O-METHOXY ARYL ACID | ROHM AND HAAS COMPANY (US) | 1983-12-27 | — | — | US | claimed |
| EP-0083978-A1 | Polymer compositions and their use in or as adhesive and other compositions | ROHM AND HAAS COMPANY (US) | 1983-07-20 | — | — | EP | claimed |
| US-4360638-A | CARBOXYLIC ACID POLYMER, METAL SALT, O-METHOXYARYLCARBOXYLIC ACID | ROHM AND HAAS COMPANY (US) | 1982-11-23 | — | — | US | claimed |
| EP-4720044-A1 | AROMATIC AMIDES AND CONJUGATES THEREOF AS BINDERS TO TEAD | Beactica Therapeutics AB (SE) | 2026-04-08 | — | — | EP | disclosed |
| US-20260027096-A1 | PHD INHIBITORS | UNIV OXFORD INNOVATION LTD (GB) | 2026-01-29 | — | — | US | disclosed |
| EP-4655288-A1 | PHD INHIBITORS | Oxford University Innovation Limited (GB) | 2025-12-03 | — | — | EP | disclosed |
| US-4328155-A | ANTIEMETIC OR PSYCHOTROPIC AGENT | SHIONOGI & CO., LTD. (JP) | 1982-05-04 | — | — | US | disclosed |
| US-4299834-A | INOTROPIC ACTIVITY | BOEHRINGER INGELHEIM GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1981-11-10 | — | — | US | disclosed |
| EP-0024290-A1 | 8-Phenyl purines, their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1981-03-04 | — | — | EP | disclosed |
| US-3975537-A | SUBSTITUTED BENZOFURANS | SMITH KLINE (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027096-A1 | PHD INHIBITORS | HIF1AN, HIF1A, EGLN1 | ALDH1A1 113/4885TSHR 4487/4885CASP1 2986/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | ALDH1A1 1569/4885TSHR 2894/4885CASP1 2603/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | ALDH1A1 1723/4885TSHR 4082/4885CASP1 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.